Xact Kapitalforvaltning’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Xact Kapitalforvaltning's DGX Position: Q1 2020 in Review
Xact Kapitalforvaltning reduced its Quest Diagnostics (DGX) stake by 15% in Q1 2020, selling an estimated $665K and leaving 37,259 shares worth $2.99M. The position accounts for 0.06% of the portfolio, ranked #255.
Xact Kapitalforvaltning first reported a position in DGX in Q3 2016 and has held it in 15 quarters since. The position peaked at $4.75M in Q3 2019. 715 funds tracked by Wall St. Rank hold DGX as of Q1 2020.
- Xact Kapitalforvaltning held 37,259 shares of Quest Diagnostics worth $2.99M as of Q1 2020.
- Xact Kapitalforvaltning sold 6,424 Quest Diagnostics shares in Q1 2020, an estimated $665K.
- Quest Diagnostics made up 0.06% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #255 holding.
- Xact Kapitalforvaltning first reported a position in Quest Diagnostics in Q3 2016 and has held it in 15 quarters since.
- Xact Kapitalforvaltning's Quest Diagnostics position peaked at $4.75M in Q3 2019.
- 715 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.
Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.